Omega Healthcare Investors (OHI) Q2 2024 earnings summary

Executive summary

• Q2 2024 net income was $117.1 million ($0.45/share), up from $61.5 million ($0.25/share) in Q2 2023, reflecting strong improvement from accretive investments and portfolio restructurings.

• NAREIT FFO for Q2 2024 was $189 million ($0.72/share), up from $155 million ($0.63/share) year-over-year; Adjusted FFO was $185 million ($0.71/share), nearly flat year-over-year.

• Q2 FAD was $177 million ($0.68/share), exceeding expectations and up from $173 million ($0.70/share) in Q2 2023.

• Dividend payout ratio dropped below 100% and a $0.67/share dividend was declared for Q2 2024, consistent with prior quarters.

• 2024 AFFO guidance was raised to $2.78–$2.84 per share, reflecting portfolio transitions, acquisitions, and improved tenant metrics.

Financial highlights

• Q2 2024 revenue was $253 million, up from $250 million in Q2 2023, driven by operator restructurings, transitions, and new investments.

• Q2 2024 expenses were $149.9 million, down $51.5 million year-over-year, mainly due to lower credit loss provisions, impairments, depreciation, and interest expense.

• Q2 2024 gain on asset sales was $12.9 million; $8.2 million net impairment charge recorded.

• Maplewood paid $11.8 million in Q2 rent, up from $11.3 million in Q1; LaVie’s rent doubled to $3 million/month in June.

• Cash, cash equivalents, and restricted cash totaled $39.1 million at June 30, 2024, down from $356.5 million at year-end 2023.

Outlook and guidance

• Full-year adjusted FFO guidance increased to $2.78–$2.84 per share, assuming $648 million in new investments, $77 million in asset sales, and stable interest rates.

• Guidance assumes stable revenue from accrual-basis operators, continued LaVie and Maplewood rent payments, and Guardian’s new operator maintaining $2.8 million/quarter rent.

• Management remains cautious due to operator financial stress, labor shortages, and regulatory changes, especially new federal minimum staffing requirements.

• Guidance excludes additional acquisitions, asset sales, certain revenue/expense items, and further credit loss provisions.